Next Issue
Volume 10, December
Previous Issue
Volume 10, October
 
 

Tomography, Volume 10, Issue 11 (November 2024) – 11 articles

Cover Story (view full-size image): Micro-computed tomography (micro-CT) is an imaging technique that provides highly detailed 3D visualizations of target specimens. In breast cancer research, micro-CT has emerged as a promising tool for analyzing microcalcifications (MCs)—tiny calcium deposits which may serve as early indicators of malignancy. The applications of micro-CT in this field are diverse, spanning ex vivo studies, animal models, and phantoms. Its use includes imagining feasibility and optimization for breast MC detection/diagnosis, comparisons and synergies with other modalities, scanner and algorithm development, and the enhancement of MC detection using contrast agents. This scoping review explores the current state of micro-CT in breast MC analysis, highlighting its potential to deepen our understanding of MC characteristics. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
20 pages, 5713 KiB  
Article
A Comparison of the Sensitivity and Cellular Detection Capabilities of Magnetic Particle Imaging and Bioluminescence Imaging
by Sophia Trozzo, Bijita Neupane and Paula J. Foster
Tomography 2024, 10(11), 1846-1866; https://doi.org/10.3390/tomography10110135 - 20 Nov 2024
Viewed by 901
Abstract
Background: Preclinical cell tracking is enhanced with a multimodal imaging approach. Bioluminescence imaging (BLI) is a highly sensitive optical modality that relies on engineering cells to constitutively express a luciferase gene. Magnetic particle imaging (MPI) is a newer imaging modality that directly detects [...] Read more.
Background: Preclinical cell tracking is enhanced with a multimodal imaging approach. Bioluminescence imaging (BLI) is a highly sensitive optical modality that relies on engineering cells to constitutively express a luciferase gene. Magnetic particle imaging (MPI) is a newer imaging modality that directly detects superparamagnetic iron oxide (SPIO) particles used to label cells. Here, we compare BLI and MPI for imaging cells in vitro and in vivo. Methods: Mouse 4T1 breast carcinoma cells were transduced to express firefly luciferase, labeled with SPIO (ProMag), and imaged as cell samples after subcutaneous injection into mice. Results: For cell samples, the BLI and MPI signals were strongly correlated with cell number. Both modalities presented limitations for imaging cells in vivo. For BLI, weak signal penetration, signal attenuation, and scattering prevented the detection of cells for mice with hair and for cells far from the tissue surface. For MPI, background signals obscured the detection of low cell numbers due to the limited dynamic range, and cell numbers could not be accurately quantified from in vivo images. Conclusions: It is important to understand the shortcomings of these imaging modalities to develop strategies to improve cellular detection sensitivity. Full article
Show Figures

Figure 1

14 pages, 2321 KiB  
Article
Tumor Morphology for Prediction of Poor Responses Early in Neoadjuvant Chemotherapy for Breast Cancer: A Multicenter Retrospective Study
by Wen Li, Nu N. Le, Rohan Nadkarni, Natsuko Onishi, Lisa J. Wilmes, Jessica E. Gibbs, Elissa R. Price, Bonnie N. Joe, Rita A. Mukhtar, Efstathios D. Gennatas, John Kornak, Mark Jesus M. Magbanua, Laura J. van’t Veer, Barbara LeStage, Laura J. Esserman and Nola M. Hylton
Tomography 2024, 10(11), 1832-1845; https://doi.org/10.3390/tomography10110134 - 20 Nov 2024
Viewed by 830
Abstract
Background: This multicenter and retrospective study investigated the additive value of tumor morphologic features derived from the functional tumor volume (FTV) tumor mask at pre-treatment (T0) and the early treatment time point (T1) in the prediction of pathologic outcomes for breast cancer patients [...] Read more.
Background: This multicenter and retrospective study investigated the additive value of tumor morphologic features derived from the functional tumor volume (FTV) tumor mask at pre-treatment (T0) and the early treatment time point (T1) in the prediction of pathologic outcomes for breast cancer patients undergoing neoadjuvant chemotherapy. Methods: A total of 910 patients enrolled in the multicenter I-SPY 2 trial were included. FTV and tumor morphologic features were calculated from the dynamic contrast-enhanced (DCE) MRI. A poor response was defined as a residual cancer burden (RCB) class III (RCB-III) at surgical excision. The area under the receiver operating characteristic curve (AUC) was used to evaluate the predictive performance. The analysis was performed in the full cohort and in individual sub-cohorts stratified by hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status. Results: In the full cohort, the AUCs for the use of the FTV ratio and clinicopathologic data were 0.64 ± 0.03 (mean ± SD [standard deviation]). With morphologic features, the AUC increased significantly to 0.76 ± 0.04 (p < 0.001). The ratio of the surface area to volume ratio between T0 and T1 was found to be the most contributing feature. All top contributing features were from T1. An improvement was also observed in the HR+/HER2- and triple-negative sub-cohorts. The AUC increased significantly from 0.56 ± 0.05 to 0.70 ± 0.06 (p < 0.001) and from 0.65 ± 0.06 to 0.73 ± 0.06 (p < 0.001), respectively, when adding morphologic features. Conclusion: Tumor morphologic features can improve the prediction of RCB-III compared to using FTV only at the early treatment time point. Full article
(This article belongs to the Section Cancer Imaging)
Show Figures

Figure 1

18 pages, 1591 KiB  
Review
Evolving and Novel Applications of Artificial Intelligence in Abdominal Imaging
by Mark R. Loper and Mina S. Makary
Tomography 2024, 10(11), 1814-1831; https://doi.org/10.3390/tomography10110133 - 18 Nov 2024
Viewed by 779
Abstract
Advancements in artificial intelligence (AI) have significantly transformed the field of abdominal radiology, leading to an improvement in diagnostic and disease management capabilities. This narrative review seeks to evaluate the current standing of AI in abdominal imaging, with a focus on recent literature [...] Read more.
Advancements in artificial intelligence (AI) have significantly transformed the field of abdominal radiology, leading to an improvement in diagnostic and disease management capabilities. This narrative review seeks to evaluate the current standing of AI in abdominal imaging, with a focus on recent literature contributions. This work explores the diagnosis and characterization of hepatobiliary, pancreatic, gastric, colonic, and other pathologies. In addition, the role of AI has been observed to help differentiate renal, adrenal, and splenic disorders. Furthermore, workflow optimization strategies and quantitative imaging techniques used for the measurement and characterization of tissue properties, including radiomics and deep learning, are highlighted. An assessment of how these advancements enable more precise diagnosis, tumor description, and body composition evaluation is presented, which ultimately advances the clinical effectiveness and productivity of radiology. Despite the advancements of AI in abdominal imaging, technical, ethical, and legal challenges persist, and these challenges, as well as opportunities for future development, are highlighted. Full article
Show Figures

Figure 1

16 pages, 1419 KiB  
Conference Report
Conference Report: Review of Clinical Implementation of Advanced Quantitative Imaging Techniques for Personalized Radiotherapy
by Yevgeniy Vinogradskiy, Houda Bahig, Nicholas W. Bucknell, Jeffrey Buchsbaum and Hui-Kuo George Shu
Tomography 2024, 10(11), 1798-1813; https://doi.org/10.3390/tomography10110132 - 14 Nov 2024
Viewed by 588
Abstract
The topic of quantitative imaging in radiation therapy was presented as a “Masterclass” at the 2023 annual meeting of the American Society of Radiation Oncology (ASTRO). Dual-energy computed tomography (CT) and single-positron computed tomography were reviewed in detail as the first portion of [...] Read more.
The topic of quantitative imaging in radiation therapy was presented as a “Masterclass” at the 2023 annual meeting of the American Society of Radiation Oncology (ASTRO). Dual-energy computed tomography (CT) and single-positron computed tomography were reviewed in detail as the first portion of the meeting session, with data showing utility in many aspects of radiation oncology including treatment planning and dose response. Positron emission tomography/CT scans evaluating the functional volume of lung tissue so as to provide optimal avoidance of healthy lungs were presented second. Advanced brain imaging was then discussed in the context of different forms of magnetic resonance scanning methods as the third area noted with significant discussion of ongoing research programs. Quantitative image analysis was presented to provide clinical utility for the analysis of patients with head and neck cancer. Finally, quality assurance was reviewed for different forms of quantitative imaging given the critical nature of imaging when numerical valuation, not just relative contrast, plays a crucial role in clinical process and decision-making. Conclusions and thoughts are shared in the conclusion, noting strong data supporting the use of quantitative imaging in radiation therapy going forward and that more studies are needed to move the field forward. Full article
(This article belongs to the Special Issue Progress in the Use of Advanced Imaging for Radiation Oncology)
Show Figures

Figure 1

18 pages, 366 KiB  
Review
Head and Neck Squamous Cell Carcinoma: Insights from Dual-Energy Computed Tomography (DECT)
by Eleonora Bicci, Antonio Di Finizio, Leonardo Calamandrei, Francesca Treballi, Francesco Mungai, Stefania Tamburrini, Giacomo Sica, Cosimo Nardi, Luigi Bonasera and Vittorio Miele
Tomography 2024, 10(11), 1780-1797; https://doi.org/10.3390/tomography10110131 - 11 Nov 2024
Viewed by 727
Abstract
Head and neck cancer represents the seventh most common neoplasm worldwide, with squamous cell carcinoma being the most represented histologic variant. The rising incidence of the neoplastic pathology of this district, coupled with the drastic changes in its epidemiology over the past decades, [...] Read more.
Head and neck cancer represents the seventh most common neoplasm worldwide, with squamous cell carcinoma being the most represented histologic variant. The rising incidence of the neoplastic pathology of this district, coupled with the drastic changes in its epidemiology over the past decades, have posed significant challenges to physicians worldwide in terms of diagnosis, prognosis, and treatment. In order to meet these challenges, a considerable amount of effort has been spent by the authors of the recent literature to explore new technologies and their possible employment for the better diagnostic and prognostic definition of head and neck squamous cell carcinoma (HNSCC). Among these technologies, a growing interest has been gathering around the possible applications of dual-energy computed tomography (DECT) in head and neck pathology. Dual-energy computed tomography (DECT) utilizes two distinct X-ray energy spectra to obtain two datasets in a single scan, allowing for material differentiation based on unique attenuation profiles. DECT offers key benefits such as enhanced contrast resolution, reduced beam-hardening artifacts, and precise iodine quantification through monochromatic reconstructions. It also creates material decomposition images, like iodine maps, aiding in tumor characterization and therapy assessment. This paper aims to summarize recent findings on the use of DECT in HNSCC, providing a comprehensive overview to aid further research and exploration in the field. Full article
13 pages, 1596 KiB  
Article
Combining Transarterial Embolization and Percutaneous Cryoablation for Early-Stage Renal Cell Carcinoma: Embolization Materials and Impacts of Tumor Size
by Miki Terauchi, Tsuneo Yamashiro, Shungo Sawamura, Shingo Koyama, Noboru Nakaigawa, Keiichi Kondo, Hisashi Hasumi, Kazuhide Makiyama and Daisuke Utsunomiya
Tomography 2024, 10(11), 1767-1779; https://doi.org/10.3390/tomography10110130 - 7 Nov 2024
Viewed by 800
Abstract
Background/Objectives: Our aim was to compare the complication rates of different embolization materials (absolute ethanol and gelatin sponges) used for combined transarterial embolization (TAE) and to investigate the impact of tumor size on operative time and cryoneedle use during percutaneous cryoablation (PCA). Methods: [...] Read more.
Background/Objectives: Our aim was to compare the complication rates of different embolization materials (absolute ethanol and gelatin sponges) used for combined transarterial embolization (TAE) and to investigate the impact of tumor size on operative time and cryoneedle use during percutaneous cryoablation (PCA). Methods: We treated 27 patients (9 women and 18 men; mean age, 74 years) with 28 early-stage (T1a) renal cell carcinoma (RCC) lesions using combined TAE and PCA between September 2018 and January 2021. During TAE, 15 lesions in 14 patients were embolized using mixed absolute ethanol and iodized oil. The remaining 13 lesions (in 13 patients) were embolized using a gelatin sponge followed by iodized oil. The PCA was performed within 3 to 21 days of the TAE. We compared complications between the TAE subgroups (i.e., absolute ethanol and gelatin sponge) and assessed potential correlations between tumor size and the operative time of the PCA. Results: All patients were successfully treated by combined TAE-PCA. Local control was achieved for all patients (monitoring period, 1–48 months; median, 28 months). Although the effect of TAE did not differ between subgroups, a significantly higher number of patients in the absolute ethanol group experienced intraprocedural pain than in the gelatin sponge group (p < 0.05). The operative time of the PCA was significantly correlated with the size of the RCC lesion (p < 0.01). The number of cryoneedles used for the PCA was also correlated with the size of the RCC lesion (p < 0.0001). Conclusions: For TAE prior to PCA for early-stage RCC, gelatin sponges can replace absolute ethanol to reduce intraprocedural pain. Tumor size correlates with operative time and the number of cryoneedles needed for PCA, which suggests the total medical cost for PCA therefore varies based on the tumor’s size. Full article
Show Figures

Figure 1

13 pages, 2156 KiB  
Article
Comparative Analysis of CT Fluoroscopy Modes and Gastropexy Techniques in CT-Guided Percutaneous Radiologic Gastrostomy
by Michael P. Brönnimann, Mauro Tarca, Laura Segger, Jagoda Kulagowska, Florian N. Fleckenstein, Bernhard Gebauer, Uli Fehrenbach, Federico Collettini, Johannes T. Heverhagen and Timo A. Auer
Tomography 2024, 10(11), 1754-1766; https://doi.org/10.3390/tomography10110129 - 6 Nov 2024
Cited by 1 | Viewed by 664
Abstract
Background/Objectives: This study was conducted to compare two modes of computed tomography fluoroscopy (CTF) and two gastropexy techniques used in CT-guided percutaneous radiologic gastrostomy (CT-PRG) aiming to identify the optimal techniques for image guidance and gastropexy and, thus, to overcome the current lack [...] Read more.
Background/Objectives: This study was conducted to compare two modes of computed tomography fluoroscopy (CTF) and two gastropexy techniques used in CT-guided percutaneous radiologic gastrostomy (CT-PRG) aiming to identify the optimal techniques for image guidance and gastropexy and, thus, to overcome the current lack of consensus on the preferred modalities. Methods: We retrospectively identified 186 successful CT-PRG procedures conducted evenly across two university hospitals from January 2019 to December 2023. Patients were divided into two groups (intermittent multislice CT biopsy mode-guided technique (MS-CT BM) and retention anchor suture (T-fastener) versus real-time (RT-)CTF and gastropexy device) for descriptive analysis of demographics, indication for PRG, radiation exposure (DLP), procedural time, number of CT scans, gastropexy time, and complications. Differences were assessed for statistical significance using Fisher’s exact test and the Mann–Whitney U-test. Results: Our final study population comprised 100 patients (50 from each center; 62.52 ± 12.36 years, 73 men). There was a significant difference in radiation exposure between MS-CT BM (group 1) and RT-CTF (group 2), with an average dose-length product (DLP) of 56.28 mGycm×m ± 67.89 and 30.91 ± 27.53 mGycm×cm, respectively (p < 0.001). PRG with RT-CTF guidance was significantly faster than PRG with MS-CT BM, with an average difference of 10.28 min (p < 0.001). No significant difference in duration was found between the two gastropexy methods compared (retention anchor suture, 11.50 ± 5.239 s vs. gastropexy device, 11.17 ± 6.015 s; p = 0.463). Complication rates did not differ significantly either (p = 0.458). Conclusions: Our findings indicate comparable efficacy and safety of the two gastropexy methods and underscore that the choice of CTF mode for image guidance has only a small role in reducing radiation exposure in patients undergoing CT-PRG. Instead, it is essential to avoid control scans. Full article
Show Figures

Figure 1

10 pages, 1764 KiB  
Article
Correlation of Sarcopenia with Coronary Artery Disease Severity and Pericoronary Adipose Tissue Attenuation: A Coronary CT Study
by Domenico Albano, Caterina Beatrice Monti, Giovanni Antonio Risoleo, Giacomo Vignati, Silvia Rossi, Edoardo Conte, Daniele Andreini, Francesco Secchi, Stefano Fusco, Massimo Galia, Paolo Vitali, Salvatore Gitto, Carmelo Messina and Luca Maria Sconfienza
Tomography 2024, 10(11), 1744-1753; https://doi.org/10.3390/tomography10110128 - 30 Oct 2024
Viewed by 747
Abstract
Objective: To investigate the association between sarcopenia, as appraised with CT-derived muscle metrics, and cardiovascular status, as assessed via coronary CT angiography (CCTA) using the Coronary Artery Disease-Reporting and Data System (CAD-RADS) and with pericoronary adipose tissue (pCAT) metrics. Methods: A retrospective observational [...] Read more.
Objective: To investigate the association between sarcopenia, as appraised with CT-derived muscle metrics, and cardiovascular status, as assessed via coronary CT angiography (CCTA) using the Coronary Artery Disease-Reporting and Data System (CAD-RADS) and with pericoronary adipose tissue (pCAT) metrics. Methods: A retrospective observational study conducted on patients who underwent CCTA. The cross-sectional area (CSA) and attenuation values of the paravertebral muscles at the T8 level and the pectoralis major muscles at the T6 level were measured. The patient height was employed for the normalization of the skeletal muscle CSA. The pCAT attenuation around the coronary arteries was assessed, and the CAD severity was graded using the CAD-RADS reporting system. Regression analyses were performed to assess the impact of demographics, clinical factors, and CT variables on the CAD-RADS and pCAT. Results: A total of 220 patients were included (132 males, median age 65 years). Regression analyses showed the associations of CAD with age and sex (p < 0.001). Familiarity with CAD was related to the left anterior descending artery pCAT (p = 0.002) and circumflex artery pCAT (p = 0.018), whereas age was related to the left anterior descending artery pCAT (p = 0.032). Weak positive correlations were found between the lower muscle density and lower pCAT attenuation (ρ = 0.144–0.240, p < 0.039). Conclusions: This study demonstrated weak associations between the sarcopenia indicators and the cardiovascular risk, as assessed by the CAD severity and pCAT inflammation. However, these correlations were not strong predictors of CAD severity, as age and traditional cardiovascular risk factors overshadowed the impact of sarcopenia in the cardiovascular risk assessment. Full article
Show Figures

Figure 1

14 pages, 23302 KiB  
Review
A Review of Factors Affecting Radiation Dose and Image Quality in Coronary CTA Performed with Wide-Detector CT
by Yihan Fan, Tian Qin, Qingting Sun, Mengting Wang and Baohui Liang
Tomography 2024, 10(11), 1730-1743; https://doi.org/10.3390/tomography10110127 - 30 Oct 2024
Viewed by 858
Abstract
Compared with traditional invasive coronary angiography (ICA), coronary CT angiography (CCTA) has the advantages of being rapid, economical, and minimally invasive. The wide-detector CT, with its superior temporal resolution and robust three-dimensional reconstruction technology, thus enables CCTA in patients with high heart rates [...] Read more.
Compared with traditional invasive coronary angiography (ICA), coronary CT angiography (CCTA) has the advantages of being rapid, economical, and minimally invasive. The wide-detector CT, with its superior temporal resolution and robust three-dimensional reconstruction technology, thus enables CCTA in patients with high heart rates and arrhythmias, leading to a high potential for clinical application. This paper systematically summarizes wide-detector CT hardware configurations of various vendors routinely used for CCTA examinations and reviews the effects of patient heart rate and heart rate variability, scanning modality, reconstruction algorithms, tube voltage, and scanning field of view on image quality and radiation dose. In addition, novel technologies in the field of CT applied to CCTA examinations are also presented. Since this examination has a diagnostic accuracy that is highly consistent with ICA, it can be further used as a routine examination tool for coronary artery disease in clinical practice. Full article
Show Figures

Figure 1

14 pages, 422 KiB  
Review
Micro-CT Microcalcification Analysis: A Scoping Review of Current Applications and Future Potential in Breast Cancer Research
by Redona Brahimetaj, Jan Cornelis and Bart Jansen
Tomography 2024, 10(11), 1716-1729; https://doi.org/10.3390/tomography10110126 - 24 Oct 2024
Viewed by 1331
Abstract
Micro-computed tomography (micro-CT) is a non-destructive imaging technique that offers highly detailed, 3D visualizations of a target specimen. In the context of breast cancer, micro-CT has emerged as a promising tool for analyzing microcalcifications (MCs), tiny calcium deposits that can indicate at an [...] Read more.
Micro-computed tomography (micro-CT) is a non-destructive imaging technique that offers highly detailed, 3D visualizations of a target specimen. In the context of breast cancer, micro-CT has emerged as a promising tool for analyzing microcalcifications (MCs), tiny calcium deposits that can indicate at an early stage the presence of cancer. This review aimed to explore the current applications of micro-CT in analyzing breast MCs (ex vivo, animal models, and phantoms) and to identify potential avenues in scientific research. We followed PRISMA guidelines for scoping reviews, yielding 18 studies that met our criteria. The studies varied in their purposes: feasibility and optimization of micro-CT for breast cancer imaging and MC analysis/diagnosis, comparison with other imaging modalities, development of micro-CT scanners and processing algorithms, enhancement of MC detection through contrast agents, etc. In conclusion, micro-CT offers superior image quality and detailed visualization of breast tissue (especially tumor masses and MCs), surpassing traditional methods like mammography and approaching the level of detail of histology. It holds great potential to enhance our understanding of MC characteristics and breast pathologies when used as a supplementary tool. Further research will solidify its role in clinical practice and potentially expand its applications in breast cancer studies. Full article
Show Figures

Figure 1

10 pages, 2789 KiB  
Article
Evaluation of the Normal Measurements of Orbital Structures in Healthy Adult Individuals by Using a Magnetic Resonance Imaging Method
by Nazire Kiliç Şafak and Sibel Tepecik
Tomography 2024, 10(11), 1706-1715; https://doi.org/10.3390/tomography10110125 - 22 Oct 2024
Viewed by 817
Abstract
Background: This study aims to determine the normal values of orbital structures according to sex in healthy adults. Methods: Diameters of extraocular muscles, the width of the optic nerve sheath diameter, the length of the inter-zygomatic line, ocular bulb length, and globe position [...] Read more.
Background: This study aims to determine the normal values of orbital structures according to sex in healthy adults. Methods: Diameters of extraocular muscles, the width of the optic nerve sheath diameter, the length of the inter-zygomatic line, ocular bulb length, and globe position were measured in the T1-weighed MR (magnetic resonance) images in 204 orbits of 102 individuals. Results: The mean values of the diameters of the extraocular muscles in males and females were as follows: medial rectus, 3.96 ± 0.52 and 3.58 ± 0.53 mm; lateral rectus, 3.47 ± 0.61 and 3.15 ± 0.48 mm; inferior rectus, 4.47 ± 0.53 and 4.07 ± 0.48 mm; superior rectus, 4.44 ± 0.64 and 4.01 ± 0.56 mm; and superior oblique, 3.68 ± 0.49 and 3.45 ± 0.44 mm. The length of the interzygomatic line in males and females were 102.68 ± 3.89 and 96.95 ± 3.4 mm, the ocular bulb length was 23.33 ± 1.32 and 22.83 ± 1.1 mm, the globe position was 7.66 ± 1.33 and 7.3 ± 1.39 mm, and the width of the optic nerve sheath diameter was 4.65 ± 0.62 and 4.28 ± 0.51 mm, respectively. All measurements were significantly greater for males than for females (p < 0.05). Conclusions: We believe that a practical and quantitative method will be provided by this study for the diagnosis and determination of the normative values of orbital structures. Full article
(This article belongs to the Section Neuroimaging)
Show Figures

Figure 1

Previous Issue
Next Issue
Back to TopTop